This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Jobs in the state-licensed cannabis industry rose 15 percent during the past 12 months, and the industry now employs over 243,000 full-time workers, according to data compiled by Leafly.com. Additional information is available in the NORML fact-sheet , ‘Marijuana Regulation: Impact on Health, Safety, Economy.’
The enactment of adult-use cannabis legalization laws in Colorado and Washington is associated with increased tourism in both states, according to data published in the Journal of Regional Analysis & Policy. Additional information appears in the NORML fact-sheet , “Marijuana Regulation: Impact on Health, Safety, and Economy.”
The enactment of state-specific medical cannabis access laws is associated with a decline in workers’ compensation claims, according to data published in the journal Health Economics. Additional information is available in the NORML fact-sheet, “Marijuana Legalization and Impact on the Workplace,” here.
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. ” An abstract of the study, “Safety and efficacy of medical cannabis in fibromyalgia,” is online here.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
The investigation assessed the suitability of using smartphone sensor data to detect cannabis intoxication, and it had promising results. ” Repurposing Smartphone Sensor Data. To detect the incidents of use among study subjects, information was gleaned from telephone surveys, phone sensor data, and self-reported cases.
The FDA, which requested science-based data to help inform regulatory decisions for hemp-derived CBD products, has been informed by ValidCare investigators about the positive results of the study. Once completed, safety results of this study will be shared with participating brands and FDA. Read more about the study here.
Comply with relevant workplace health and safety legislation. Yesespecially in safety-sensitive industries (mining, transport, healthcare). Employers must balance workplace safety with disability discrimination laws. How should businesses handle cannabis-related workplace safety concerns? Data Privacy 29.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
The enactment of statewide legislation permitting adult cannabis possession and sales is not associated with any significant or long-term uptick in criminal activity, according to data published in the journal Justice Quarterly. Additional information is available from the NORML fact-sheet , ‘Marijuana Regulation and Crime Rates.’
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. For more information, contact Jenn Michelle Pedini, NORML Development Director & Virginia NORML Executive Director.
” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. ” For more information on the public health and safety of cannabis, please see NORML’s fact-sheets here.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. For more information, contact Jenn Michelle Pedini , NORML Development Director & Virginia NORML Executive Director.
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. Clinical trial information: NCT03276572 ( [link] ).
The New York State Association of Police said traffic safety is a major concern, citing an increase in vehicle-related fatalities by 62 percent in Colorado the first year cannabis was legalized in the state. Please visit www.rocnorml.org for more information about how you can get involved and follow ROC NORML on Facebook and Twitter. .
Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”
Thailand left its war on drugs in the past, the Texas GOP platform raised some questions, and a new study revealed how cannabis legalization affects road safety. Study Finds Cannabis Legalization Increases Road Safety. It looked at car insurance data from 2014 to 2019 to see how medical cannabis legalization affected premium prices.
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
Hemp Roundtable (“the Roundtable”) appreciates the opportunity to provide comments to FDA in response to its request for scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.
General information regarding cannabis reform: According to the most recent FBI Uniform Crime Report , police made 659,700 arrests for marijuana-related violations in 2017. The enactment of these policies have not negatively impacted workplace safety , crime rates , traffic safety , or youth use patterns.
This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”. Jake Felice, a naturopathic medicine practitioner who consults for cannabis businesses in Washington state seeking medicinal approval, said any data collection system for patients should be far-reaching.
This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. The information presented here should be interpreted with caution. 13-283 (C.R.S.
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.
Marketing, labeling and sales : How should consumers be informed about the risks associated with such products (e.g., What specific risks should consumers be informed about? For more information on ways to mitigate the risk of FDA and FTC enforcement actions, contact our team of regulatory attorneys.
As safety and compliance testing regulations evolve, it will be important to include more than the standard As, Cd, Hg, and Pb to the list of regulated metals. Supporting Information. The Supporting Information is available free of charge at [link]. Mugglehead have a good analysis at.
We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.
La Jolla, CA: The establishment of licensed cannabis retailers is not independently associated with an increase in traffic crashes, according to data published in the journal Health Economics. Full text of the study, “Does expanding access to cannabis affect traffic crashes?
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.
This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. The data tool can be found on the DCC website here: [link]. Tweet this.
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.
In addition, the FDA reiterates its view that Hemp-CBD cannot be added to food or dietary supplements and states that it “cannot conclude that CBD is generally recognized as safe (GRAS) among qualified experts for its use in human or animal food” based on the available data. Consumer Update. Conclusion.
By focusing on this specific demographic, the team aimed to not only collect raw data but also gain insights into the motivations and experiences that led these caregivers to explore CBD as a therapeutic option for their children. Do not attempt to self-diagnose or prescribe treatment based on the information provided.
Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.
“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.
Public Health and Data Monitoring. Lab Testing and Product Safety. Impaired Driving and Traffic Safety. Their work informed several letters to Congress regarding national cannabis policy priorities and comments on proposed federal legislation to legalize cannabis federally. Social and Economic Equity. Public Education.
This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. The information presented here should be interpreted with caution. 13-283 (C.R.S.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
WORCESTER —On the eve of Wednesday, September 1, the Cannabis Control Commission (Commission)’s fourth birthday, adult-use Marijuana Establishments in Massachusetts surpassed $2 billion in gross sales , according to information reported in the state’s mandatory seed-to-sale tracking system, the agency announced today.
An example of these laboratories is Praxis Laboratory which was said to have provided falsified testing data for more than 1,200 cannabis products. The lab appealed the statement by stating that their shutdown was based “in error and based on inaccurate information”.
There is a lot of information out there about the cannabis industry and its regulatory structure, but not much is known about consumers,” said Zach Knowling, vice president at Quinn Thomas, in an email. Indeed, the survey data show that recreational-cannabis consumers look pretty much like the average American.
Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. A combination of factors has led the FDA to provide consumers with this information. For more information about Delta-8 THC: CDC HEALTH ALERT NETWORK (HAN). exposures to any substance(s).
In response to Senator Wyden and other stakeholders’ demands, FDA Acting Chief Information Officer, Amy Abernethy, recently announced on Twitter that: [FDA] is expediting its work to address the many questions about cannabidiol (CBD). Four days before the deadline, over three thousand comments had been published on the public docket.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content